Viewing StudyNCT04712890



Ignite Creation Date: 2024-05-06 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 1:54 PM
Study NCT ID: NCT04712890
Status: COMPLETED
Last Update Posted: 2023-09-28
First Post: 2021-01-08

Brief Title: Determination of Prevalence and Features of HRRm mCRPC ADAM
Sponsor:
Organization: AstraZeneca

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 331
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
71822
Who Masked List: